Luke Sergott
Stock Analyst at Barclays
(2.06)
# 2,926
Out of 4,944 analysts
306
Total ratings
37.28%
Success rate
-6.69%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Overweight | $190 → $210 | $159.81 | +31.41% | 4 | Aug 8, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $13 → $15 | $12.81 | +17.10% | 13 | Aug 8, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $5 → $6 | $7.31 | -17.92% | 11 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $65 → $55 | $41.74 | +31.77% | 6 | Aug 7, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $155 → $165 | $152.75 | +8.02% | 8 | Aug 7, 2025 | |
| BRKR Bruker | Maintains: Overweight | $46 → $43 | $32.36 | +32.88% | 5 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Overweight | $15 → $13 | $12.66 | +2.69% | 25 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Underweight | $85 → $90 | $97.38 | -7.58% | 19 | Aug 1, 2025 | |
| INCY Incyte | Initiates: Overweight | $90 | $81.61 | +10.28% | 1 | Aug 1, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Equal-Weight | $155 → $180 | $169.08 | +6.46% | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $450 → $490 | $477.41 | +2.64% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $300 → $450 | $459.29 | -2.02% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $185 | $185.91 | -0.49% | 23 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.21 | +23.97% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $14.86 | -12.52% | 21 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $215 → $225 | $205.72 | +9.37% | 40 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $115 → $125 | $117.32 | +6.55% | 9 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $245 | $239.90 | +2.13% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $121.40 | +23.56% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $48.97 | +12.31% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,325 | $1,292.89 | +2.48% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $11 → $14 | $10.75 | +30.23% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $55.10 | +8.89% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $285.52 | +22.58% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $27.45 | +63.93% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $88.00 | +25.00% | 9 | Apr 10, 2025 |
Natera
Aug 8, 2025
Maintains: Overweight
Price Target: $190 → $210
Current: $159.81
Upside: +31.41%
10x Genomics
Aug 8, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $12.81
Upside: +17.10%
Fortrea Holdings
Aug 7, 2025
Maintains: Underweight
Price Target: $5 → $6
Current: $7.31
Upside: -17.92%
Exact Sciences
Aug 7, 2025
Maintains: Overweight
Price Target: $65 → $55
Current: $41.74
Upside: +31.77%
Charles River Laboratories International
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $155 → $165
Current: $152.75
Upside: +8.02%
Bruker
Aug 4, 2025
Maintains: Overweight
Price Target: $46 → $43
Current: $32.36
Upside: +32.88%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $12.66
Upside: +2.69%
Illumina
Aug 1, 2025
Maintains: Underweight
Price Target: $85 → $90
Current: $97.38
Upside: -7.58%
Incyte
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $81.61
Upside: +10.28%
ICON Public Limited Company
Jul 25, 2025
Maintains: Equal-Weight
Price Target: $155 → $180
Current: $169.08
Upside: +6.46%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $450 → $490
Current: $477.41
Upside: +2.64%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $300 → $450
Current: $459.29
Upside: -2.02%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $165 → $185
Current: $185.91
Upside: -0.49%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.21
Upside: +23.97%
Jun 24, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $14.86
Upside: -12.52%
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $205.72
Upside: +9.37%
Jun 24, 2025
Maintains: Equal-Weight
Price Target: $115 → $125
Current: $117.32
Upside: +6.55%
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $245
Current: $239.90
Upside: +2.13%
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $121.40
Upside: +23.56%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $48.97
Upside: +12.31%
Jun 24, 2025
Initiates: Overweight
Price Target: $1,325
Current: $1,292.89
Upside: +2.48%
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $10.75
Upside: +30.23%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $55.10
Upside: +8.89%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $285.52
Upside: +22.58%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $27.45
Upside: +63.93%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $88.00
Upside: +25.00%